Holen Sie sich die Stockscreener-App
8.63
6.54%
0.53
Handel nachbörslich:
8.28
-0.35
-4.06%
Schlusskurs vom Vortag:
$8.10
Offen:
$8
24-Stunden-Volumen:
1.84M
Relative Volume:
1.27
Marktkapitalisierung:
$1.34B
Einnahmen:
$53.61M
Nettoeinkommen (Verlust:
$-142.52M
KGV:
-7.7748
EPS:
-1.11
Netto-Cashflow:
$-141.83M
1W Leistung:
+2.74%
1M Leistung:
+32.46%
6M Leistung:
-25.41%
1J Leistung:
+40.10%
1-Tages-Spanne:
$7.93
$8.70
1-Wochen-Bereich:
$7.75
$8.88
52-Wochen-Spanne:
$5.04
$16.73
Wave Life Sciences Ltd Stock (WVE) Company Profile
Firmenname
Wave Life Sciences Ltd
Sektor
Branche
Telefon
617-949-2900
Adresse
7 STRAITS VIEW, SINGAPORE
Vergleichen Sie WVE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
WVE
Wave Life Sciences Ltd
|
8.63 | 1.29B | 53.61M | -142.52M | -141.83M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Wave Life Sciences Ltd Stock (WVE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-28 | Eingeleitet | Oppenheimer | Outperform |
| 2025-07-16 | Eingeleitet | Citigroup | Buy |
| 2025-06-11 | Fortgesetzt | Raymond James | Outperform |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2025-04-08 | Eingeleitet | Wedbush | Outperform |
| 2025-02-25 | Eingeleitet | Jefferies | Buy |
| 2024-10-16 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2024-09-27 | Fortgesetzt | JP Morgan | Overweight |
| 2024-09-19 | Eingeleitet | B. Riley Securities | Buy |
| 2024-09-09 | Eingeleitet | JP Morgan | Overweight |
| 2024-05-15 | Eingeleitet | Wells Fargo | Overweight |
| 2023-12-19 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2023-07-05 | Eingeleitet | Raymond James | Outperform |
| 2023-05-24 | Herabstufung | Jefferies | Buy → Hold |
| 2020-12-15 | Fortgesetzt | H.C. Wainwright | Buy |
| 2020-10-23 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-12-31 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2019-11-01 | Eingeleitet | Guggenheim | Buy |
| 2019-07-15 | Eingeleitet | Cowen | Market Perform |
| 2019-04-17 | Bestätigt | H.C. Wainwright | Buy |
| 2018-08-07 | Eingeleitet | Stifel | Buy |
| 2018-07-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2018-03-19 | Bestätigt | Mizuho | Buy |
| 2017-02-15 | Eingeleitet | H.C. Wainwright | Buy |
| 2016-11-10 | Fortgesetzt | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2015-12-07 | Eingeleitet | Jefferies | Buy |
| 2015-12-07 | Eingeleitet | Leerink Partners | Outperform |
| 2015-12-07 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Wave Life Sciences Ltd Aktie (WVE) Neueste Nachrichten
How does Wave Life Sciences Ltd. compare to its industry peersStock Market Data Feed For Consistent Profits - jammulinksnews.com
How strong is Wave Life Sciences Ltd. company’s balance sheetSmart Portfolio Outlook For Consistent Profits - jammulinksnews.com
Why is Wave Life Sciences Ltd. stock attracting strong analyst attentionPost Market Updates For Consistent Profits - jammulinksnews.com
Wave Life Sciences Second Quarter 2025 Earnings: Misses Expectations - simplywall.st
Wave Life Sciences Ltd. (NASDAQ:WVE) Q2 2025 Earnings Call Transcript - Insider Monkey
Need To Know: The Consensus Just Cut Its Wave Life Sciences Ltd. (NASDAQ:WVE) Estimates For 2025 - Yahoo Finance
Wave Life Sciences signals key Q3 and Q4 data catalysts as INHBE and AATD programs advance - MSN
Wave Life Sciences Earnings Call: Clinical Advances Amid Financial Challenges - TipRanks
Is it the right time to buy Wave Life Sciences Ltd. stockStock Strategy Recommendation From AI Tools - jammulinksnews.com
Wave (WVE) Q2 Revenue Drops 56% - AOL.com
Wave Life Sciences Ltd.'s (NASDAQ:WVE) 26% Share Price Surge Not Quite Adding Up - simplywall.st
What catalysts could drive Wave Life Sciences Ltd. stock higher in 2025Expert Picks Tips For Beginners - jammulinksnews.com
Wave Life Sciences (WVE) Reports Q2 Loss, Misses Revenue Estimates - sharewise.com
WAVE Life Sciences Ltd (WVE) Q2 2025 Earnings Call Highlights: Progress in RNA Editing Amid ... - Yahoo Home
Wave (WVE) Q2 Revenue Drops 56% - The Motley Fool
Wave Life Sciences Advances RNA Medicine Pipeline - TipRanks
WAVE Life Sciences Q2 2025 Earnings Call Transcript - MarketBeat
Wave Life Sciences 2025 Q2 Earnings Revenue Drops 56%, Net Loss Widens - AInvest
Wave Life Sciences: Q2 Earnings Snapshot - Greenwich Time
Top Risks to Consider Before Buying Wave Life Sciences Ltd. StockOversold Recovery Opportunity Stocks Attract Buyers - metal.it
WaveLife Flat on Q2 Results - Baystreet.ca
WAVE Life Sciences Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Wave Life Sciences Ltd earnings missed by $0.04, revenue fell short of estimates - Investing.com Nigeria
Wave Life Sciences Ltd. SEC 10-Q Report - TradingView
Wave Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update - TradingView
What makes Wave Life Sciences Ltd. stock price move sharplyLow Risk Picks for Daily Trading Released - metal.it
Insights Into WAVE Life Sciences's Upcoming Earnings - 富途牛牛
Wave Life Sciences Q2 2025 Earnings Preview - MSN
What is the risk reward ratio of investing in Wave Life Sciences Ltd. stockSuperior risk-adjusted returns - jammulinksnews.com
This MongoDB Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday - Benzinga
What are the latest earnings results for Wave Life Sciences Ltd.Maximize your returns with expert insights - jammulinksnews.com
Oppenheimer initiates Wave Life Sciences stock with Outperform rating - Investing.com Australia
Oppenheimer initiates Wave Life Sciences stock with Outperform rating By Investing.com - Investing.com South Africa
Wave Life Sciences WVE Q2 2025 Earnings Preview Upside Potential on Clinical Progress and Operational Adjustments - AInvest
How many analysts rate Wave Life Sciences Ltd. as a “Buy”Track top-performing stocks in real-time - jammulinksnews.com
When is Wave Life Sciences Ltd. stock expected to show significant growthCapitalize on strong market momentum - jammulinksnews.com
What is the dividend policy of Wave Life Sciences Ltd. stockAchieve breakthrough profits with expert advice - jammulinksnews.com
What are analysts’ price targets for Wave Life Sciences Ltd. in the next 12 monthsFree Investment Portfolio Suggestions - jammulinksnews.com
Wave Life Sciences Ltd. Stock Analysis and ForecastSuperior profit margins - PrintWeekIndia
What risks could impact Wave Life Sciences Ltd. stock performanceConsistently exceptional gains - jammulinksnews.com
What analysts say about Wave Life Sciences Ltd. stockExplosive trading growth - PrintWeekIndia
Finanzdaten der Wave Life Sciences Ltd-Aktie (WVE)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.93%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):